Interleukin 15: A potential player during the innate immune response to infection

Experimental Parasitology

Volumn 84, Issue 2, 1996, Pages 291-294

  Carson, William E ^a   Caligiuri, Michael A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15;

HUMAN; IMMUNE RESPONSE; INFECTION; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; REVIEW;

EID: 0030298229     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1996.0115     Document Type: Article

References (19)

1. ANDERSON, A., SATORU, K., AHDIEH, M., BERTLES, J., TOMETSKO, M., LOOMIS, L., GIRI, J., COPELAND, N. G., GILBERT, D. J., JENKINS, N. A., VALENTINE, V., SHAPIRO, D. N., MORRIS, S. W., PARK, L. S., AND COSMAN, D. 1995. Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL15RA and IL2RA genes. Journal of Biological Chemistry 270, 29862-29869.
2. BANCROFT, G. J. 1993. The role of natural killer cells in innate resistance to infection. Current Opinions in Immunology 4, 503-510.
3. BIRON, C. A., AND GAZZMELLI, R. T. 1995. Effects of IL-12 on immune responses to microbial infections: A key mediator in regulating disease outcome. Current Opinions in Immunology 7, 485-496.
4. CALIGIURI, M. A., ZMUIDINAS, A., MANLEY, T. J., LEVINE, H., SMITH, K., AND RITZ, J. 1990. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. Journal of Experimental Medicine 171, 1509-1526.
5. CARSON, W. F., GIRI, J. G., LINDEMANN, M. J., LINETT, M. L., AHDIEH, M., ANDERSON, D., EISENMANN, J., GRABSTEIN, K., AND CALIGIURI, M. A. 1994. Interleukin-15 is a novel cytokine which activates human natural killer cells via components of the interleukin-2 receptor. Journal of Experimental Medicine 180, 1395-1403.
6. CARSON, W. E., ROSS, M. E., BAIOCCHI, R. A., MARIEN, M. J., BOIANI, M., GRABSTEIN, K., AND CALIGIURI, M. A. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. Journal of Clinical Investigation 96, 2578-2582.
7. CARSON, W. E., LINDEMANN, M. J., BAIOCCHI R. A., LINETT, M. L., TAN, J., CHAN, C. C., NARULA, S., AND CALIGIURI, M. A. 1995. The functional characterization of IL-10 receptor expression on human natural killer cells. Blood 85, 3577-3585.
8. DOHERTY, T. M., SEDER, R. A., AND SHER, R. A. 1996. Induction and regulation of IL-15 expression in murine macrophages. Journal of Immunology 156, 735-741.
9. GIRI, J. G., AHDIEH, M., EISENMAN, J., SHANEBECK, K., GRABSTEIN, K., PARK, L. S., COSMAN, D., ANDERSON, D. 1994. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO Journal 13, 2822-2830.
10. GIRI, J. G., KUMAKI, S., AHDIEH, M, FRIEND, D. J., LOOMIS A., SHANEBECK, K., DUBOSE, R., COSMAN, D., PARK, L. S., AND ANDERSON, D. M. 1995a. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO Journal 14, 3654-3663.
11. GIRI, J. G., ANDERSON, D. M., KUMAKI, S., PARK, L. S., GRABSTEIN, K., AND COSMAN, D. 1995b. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. Journal of Leukocyte Biology 57, 763-766.
12. GRABSTEIN, K. H., EISENMAN, J., SHANEBECK, K., RAUCH, C., SRINTVASAN, S., FUNG, V., BEERS, C., RICHARDSON, J., SCHOENBORN, M. A., AHDIEH, M., JOHNSO, L., ALDERSON, M. R., WATSON, J. D., ANDERSON, D. M., AND GIRI, J. G. 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264, 965-968.
13. MIYAZAKI, T., LIU, Z. J., KAWAHARA, A., MINIAMI, Y., YAMADA, K., TSUJIMOTO, Y., BARSOUMIAN, E. L., PERLMUTTER, R. M., AND TAMGUCHI, T. 1995. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, lck cooperate in hematopoietic cell proliferation. Cell 81, 223-231.
14. MRÖZEK, E., ANDERSON, P., AND CALIGIURI, M. A. 1996. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood 87, 2632-2640.
15. ROBERTSON, R. J. AND RITZ, J. 1990. Biology and clinical relevance of human natural killer cells. Blood 76, 2421-2438.
16. ROSS, M. E., KONO, Y. CARSON, W., TOMASI, T. B., AND CALIGIURI, M. A. 1995. Transforming growth factor-β suppresses γ-IFN production by IL-12 and IL-15 activated natural killer cells. Proceedings of the American Association for Cancer Research, Toronto, Canada, March, No. 2795.
17. SMITH, K. A. 1988. Interleukin-2: Inception, impact, and implications. Science 280, 1169-76.
18. TAGAYA, Y., BAMFORD, R. M., DEDILIPPIS, A. P., AND WALDMANN, T. A. 1996. IL-15: Apleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4, 329-336.
19. TANIGUCHI, T. 1995. Cytokine signaling through nonreceptor protein kinases. Science 268, 251-255.